Current stock page

Catalysts

IMVT Stock Catalysts

Earnings · Growth Drivers · Events · AIQ Catalyst

HealthcareBiotechnologyScore data as of Nov 13, 2026

IMVTImmunovant, Inc.

Healthcare / Biotechnology

Relative Leader / Watch

Strong Relative Position

NeutralEdge 9/10
$34.18−$0.87 (−2.48%)

Latest quote

  • Momentum
    61
  • Value
    —
  • Quality
    42
  • Risk resilience
    52
  • Sentiment
    —
algovestiq.comScore data as of Nov 13, 2026

Stock Catalyst Board

Earnings timing, analyst expectations, news pressure, growth drivers, events, and AIQ Catalyst context.

Next earnings
Feb 5, 2027

Upcoming reporting date available for this company.

AIQ Catalyst
AIQ 52/100

Momentum 61/100 and sentiment — before the next covered event.

Recent coverage
4 articles

Updated Nov 15, 2026 · Sentiment 15.02%

Earnings History And Surprises

See whether reported EPS and revenue have consistently exceeded or missed analyst expectations.

Earnings Expectations And Results

Compare what analysts expected with what the company reported across recent quarters.

Momentum 61/100AIQ Edge 9/10 Strong Relative Position
Beat rate
50%
4 of 8 reported periods
Average surprise
+3.3%
Across covered historical reports
Latest result
+36.2%
Nov 9, 2026
EPS estimate versus actual
Actual bars are colored by beat, inline result, or miss.
Earnings history
Report dateFiscal periodEPS estimateEPS actualEPS surpriseRevenue estimateRevenue actual
Nov 9, 2026—-$0.74-$0.47+36.2%——
Aug 6, 2026—-$0.63-$0.75-19.3%$7.1M$7.1M
May 20, 2026—-$0.59-$0.73-23.3%——
Feb 6, 2026—-$0.72-$0.61+15.3%$6M—
Nov 10, 2025—-$0.72-$0.73-1.4%——
Aug 11, 2025—-$0.69-$0.60+13.0%——
May 29, 2025—-$0.71-$0.64+10.3%——
Feb 6, 2025—-$0.73-$0.76-4.1%——

Analyst Forecast And Price Targets

Wall Street consensus, rating distribution, and the current 12-month target range.

Analyst ratings
Buy
13
Buy
4
Hold
12-month analyst target
—
— versus current price
Based on 17 analyst observations. Targets are estimates, not predictions.
No analyst target path in this snapshot.
Low target
—
—
Average target
—
—
High target
—
—

Event Read

Catalysts should explain what can change the setup, when it might happen, and which AIQ component would move first.

Current event setup

Event dateFeb 5, 2027

Next known earnings or reporting date.

EPS estimate-$0.68

Current analyst expectation for the upcoming report.

Sentiment score—

News pressure around the setup.

Momentum score61

Where event reaction would show up first.

AIQ score52/100

Composite decision read before event confirmation.

Analyst context

Consensus
Buy
Analysts
17

News And Sentiment

Recent company coverage, scored where source sentiment is available.

Positive
3
Neutral
1
Negative
0
gurufocus.com · Nov 9, 2026

Immunovant (IMVT) Shares Surge 16.3% Pre-Market on Rising Stock Futures

On November 09, 2026, Immunovant Inc (NASDAQ: IMVT) saw a significant pre-market price jump of 16.3%, coinciding with broad gains in stock index futures ahead o

insidermonkey.com · Sep 27, 2026

Immunovant (IMVT): One Trial Failure Doesn’t Break the Bull Case

We all have bad days. Immunovant, Inc. (NASDAQ:IMVT) had its latest bad day on September 23 after a clinical-trial setback, sending the shares lower.

gurufocus.com · Sep 23, 2026

Immunovant (IMVT) Faces Clinical Setback but Retains Strong Guru and Insider Support

On September 23, 2026, Immunovant Inc (NASDAQ: IMVT) announced that its IMVT-1402 candidate failed to meet the primary endpoint in a clinical trial for cutaneou

gurufocus.com · Sep 23, 2026

ROIV Looks 361.0% Overvalued on GF Value™

On September 23, 2026, Roivant Sciences Ltd (NASDAQ: ROIV) experienced a dip in premarket trading after its subsidiary Immunovant announced that a proof-of-conc

Open full news and sentiment

IMVT Catalysts FAQ

What are the next catalysts for IMVT stock?

IMVT's next stock catalysts can include earnings, guidance, analyst ratings, price-target changes, estimate revisions, product updates, regulatory events, contracts, or sector developments. Use this page to connect those events with AIQ and market context.

What upcoming events could move IMVT stock?

Upcoming events that could move IMVT include earnings reports, management commentary, estimate changes, major news, and market-wide sector catalysts.

How could IMVT's next earnings report affect the stock?

IMVT's next earnings report could affect the stock by changing revenue expectations, EPS estimates, guidance, analyst ratings, price targets, estimate revisions, and momentum.

What could drive IMVT stock higher?

IMVT could move higher if earnings, guidance, demand trends, analyst expectations, or AIQ momentum improve relative to what the market already expects.

What events could hurt IMVT stock?

IMVT could be hurt by weaker guidance, negative estimate revisions, margin pressure, adverse news, regulatory issues, or a sector-wide risk-off move.